Trial Profile
An open-label study of subcutaneous injection (s.c.) S-811717 (oxycodone hydrochloride solution for injection) in patients with cancer pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Aug 2022
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
- 06 Jun 2016 New trial record